Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

September 6, 2026

Study Completion Date

March 6, 2027

Conditions
Obesity
Interventions
OTHER

Blood GLP1

On the day of surgery, the surgeon will remove visceral adipose tissue (1 cm3) from the operative waste. The adipose tissue is separated into 2 samples, one frozen in nitrogen, the other embedded in formalin. The samples are then sent to the Institut de Biologie de Valrose (iBV) to assess any differences between the two groups of patients (patients treated with anti-GLP-1 analogues

OTHER

Blood No treated GLP1

On the day of surgery, the surgeon will remove visceral adipose tissue (1 cm3) from the operative waste. The adipose tissue is separated into 2 samples, one frozen in nitrogen, the other embedded in formalin. The samples are then sent to the Institut de Biologie de Valrose (iBV) to assess any differences between the two groups of patients (patients treated with patients not treated with anti-GLP-1 analogues) and the presence of fibrosis.

Trial Locations (1)

06200

RECRUITING

CHU de Nice - Hôpital de l'Archet, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER